Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

301
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
301
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

232
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
232
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

191
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
191
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

241
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
241
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

218
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
218

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and Clinical Validation of a Digital Eye-Tracking-Based Cover Test for Ocular Misalignment.

Ophthalmology science·2026
Same author

Noninvasive Cardiac Output Monitoring Combined With Critical Care Ultrasound for Postoperative Volume Management in Cardiac Surgery Patients: A Randomized Controlled Trial.

The Journal of surgical research·2026
Same author

Uncovering the neglected feedback of accumulated polyphenol toward self-enhanced electro-polymerization.

Water research·2026
Same author

Outcomes of Thermal Radiofrequency Ablation of Lumbar Medial Branches as Treatment for Chronic Low Back Pain.

Pain and therapy·2026
Same author

LncRNA PCGEM1 Promotes Endoplasmic Reticulum Stress in Osteosarcoma Cells Under Hypoxia by Activating JAK/STAT3 Signaling Pathway.

The Tohoku journal of experimental medicine·2026
Same author

Stabilizing Extreme Few-Shot ECG Classification via Self-Supervised Contrastive Pretraining.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·2026

Related Experiment Video

Updated: Jan 6, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.5K

A Preterm Physiologically Based Pharmacokinetic Model. Part I: Physiological Parameters and Model Building.

Khaled Abduljalil1, Xian Pan2, Amita Pansari2

  • 1Simcyp Division Level 2-Acero, Certara UK Limited, 1 Concourse Way, Sheffield, S1 2BJ, UK. khaled.abduljalil@certara.com.

Clinical Pharmacokinetics
|October 5, 2019
PubMed
Summary

This study integrates physiological data to create a pharmacokinetic model for preterm infants, crucial for accurate drug dosing in this vulnerable population. The model accounts for developmental changes, improving drug safety and efficacy predictions.

More Related Videos

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
07:23

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications

Published on: October 20, 2023

1.8K
Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

494

Related Experiment Videos

Last Updated: Jan 6, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.5K
Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
07:23

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications

Published on: October 20, 2023

1.8K
Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

494

Area of Science:

  • Pharmacology
  • Developmental Physiology
  • Computational Biology

Background:

  • Pharmacotherapy in preterm infants is complex due to developmental physiology.
  • Physiologically based pharmacokinetic (PBPK) models are valuable for predicting drug behavior in this population.
  • Limited availability of integrated physiological data hinders PBPK model development for preterm infants.

Purpose of the Study:

  • To compile and integrate essential physiological parameters for constructing a PBPK model specific to preterm infants.
  • To provide a comprehensive resource for researchers and clinicians involved in preterm pharmacotherapy.

Main Methods:

  • Systematic collation and analysis of published data on preterm developmental physiology.
  • Development of equations to describe the ontogeny of physiological variables and drug-metabolizing enzymes.
  • Quantification of organ size and protein binding as functions of body weight and age, respectively.

Main Results:

  • Growth patterns of organ size were quantified as functions of body weight, preserving physiological correlations.
  • Ontogeny functions were derived for key drug-metabolizing enzymes: cytochrome P450 1A2, 3A4, and 2C9.
  • Identified limitations in available data for tissue composition changes with age.

Conclusions:

  • The integrated dataset provides a foundational resource for building PBPK models in preterm populations.
  • Addresses a critical gap in data availability for optimizing drug therapy in neonates.
  • Facilitates improved prediction of drug pharmacokinetics and pharmacodynamics in preterm infants.